|
Helix Health has raised €5m of equity funding from the Ulster Bank Diageo Venture Fund. The funding will be used to strengthen Helix Health’s investment in driving export sales and to facilitate further investment in R&D projects. CEO Howard Beggs, said, “This investment by The Ulster Bank Diageo Venture Fund is a very significant step in the growth story of Helix Health. It will facilitate further investment in our products to support local and international expansion. John Dolan (pictured above) of NCB Ventures, which manages the fund, said, “Helix is a great example of an indigenous Irish company that has, through its commitment to R&D, developed an impressive range of market-leading technology solutions for the primary healthcare sector.”
|
